biotechnology

Luna is a new kind of space company helping biotech find its footing in microgravity

November 20, 2019 0

Toronto-based startup Luna Design and Innovation is a prime example of the kind of space company that is increasingly starting up to take advantage of

You’ve heard of CRISPR, now meet its newer, savvier cousin CRISPR Prime

November 16, 2019 0

CRISPR, the revolutionary ability to snip out and alter genes with scissor-like precision, has exploded in popularity over the last few years and is generally

Boston gets a new biotech accelerator with the launch of Petri

September 13, 2019 0

As biotechnology becomes more central to new innovations in healthcare, material science and manufacturing, one of the nation’s research hubs is getting a new accelerator

Benchling’s software for managing biotech research nabs $34.5 million

July 24, 2019 0

In a field where the laboratory notebook is still considered the state of the art, it’s no wonder a company like Benchling, which provides software

Union Health Ministry To Effectively Implement AI In Public Health

July 13, 2019 0

Plans are underway to use the technology in a safe and efficient way for better treatment of disease like cancer and thus, benefit more people

DNA Script picks up $38.5 million to make DNA production faster and simpler

May 18, 2019 0

DNA Script has raised $38.5 million in new financing to commercialize a process that it claims is the first big leap forward in manufacturing genetic

Indonesian startup that turns mushrooms into leather nabs 6-figure funding

April 28, 2019 0

[unable to retrieve full-text content]source : techinasia

XGenomes is bringing DNA sequencing to the masses

March 16, 2019 0

As healthcare moves toward genetically tailored treatments, one of the biggest hurdles to truly personalized medicine is the lack of fast, low-cost genetic testing. And

In brief: Thai biotech JuiceInnov8 gets 500 Startups funding

February 27, 2019 0

[unable to retrieve full-text content]source : techinasia

Up to $818 million deal between J&J and Locus Biosciences points to a new path for CRISPR therapies

January 5, 2019 0

The up to $818 million deal between Locus Biosciences and Janssen Pharmaceuticals (a division of Johnson & Johnson) that was announced yesterday points toward a

1 2